全文获取类型
收费全文 | 12488篇 |
免费 | 1076篇 |
国内免费 | 415篇 |
专业分类
耳鼻咽喉 | 29篇 |
儿科学 | 164篇 |
妇产科学 | 81篇 |
基础医学 | 933篇 |
口腔科学 | 215篇 |
临床医学 | 2294篇 |
内科学 | 3562篇 |
皮肤病学 | 105篇 |
神经病学 | 1083篇 |
特种医学 | 147篇 |
外国民族医学 | 2篇 |
外科学 | 538篇 |
综合类 | 1819篇 |
现状与发展 | 4篇 |
预防医学 | 321篇 |
眼科学 | 87篇 |
药学 | 1749篇 |
5篇 | |
中国医学 | 573篇 |
肿瘤学 | 268篇 |
出版年
2024年 | 11篇 |
2023年 | 151篇 |
2022年 | 126篇 |
2021年 | 359篇 |
2020年 | 412篇 |
2019年 | 412篇 |
2018年 | 410篇 |
2017年 | 440篇 |
2016年 | 448篇 |
2015年 | 456篇 |
2014年 | 584篇 |
2013年 | 960篇 |
2012年 | 629篇 |
2011年 | 602篇 |
2010年 | 530篇 |
2009年 | 555篇 |
2008年 | 484篇 |
2007年 | 528篇 |
2006年 | 417篇 |
2005年 | 445篇 |
2004年 | 384篇 |
2003年 | 379篇 |
2002年 | 326篇 |
2001年 | 340篇 |
2000年 | 310篇 |
1999年 | 271篇 |
1998年 | 272篇 |
1997年 | 253篇 |
1996年 | 210篇 |
1995年 | 234篇 |
1994年 | 219篇 |
1993年 | 160篇 |
1992年 | 154篇 |
1991年 | 166篇 |
1990年 | 147篇 |
1989年 | 119篇 |
1988年 | 135篇 |
1987年 | 114篇 |
1986年 | 85篇 |
1985年 | 159篇 |
1984年 | 137篇 |
1983年 | 90篇 |
1982年 | 100篇 |
1981年 | 83篇 |
1980年 | 59篇 |
1979年 | 31篇 |
1978年 | 20篇 |
1977年 | 25篇 |
1976年 | 18篇 |
1975年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 687 毫秒
61.
Continuous proteolysis resulting in consumption of major cytoskeletal proteins may be essential for platelet activation and aggregation. In this study we evaluated the effect of a known protease inhibitor, Leupeptin, on agonist induced platelet aggregation and secretion. Platelets exposed to 10 ugs/ml of Leupeptin did not aggregate in response to the action of thrombin (0.2u/ml). However, a concentration of Leupeptin as high as 250 ugs/ml did not prevent arachidonate induced aggregation and secretion. Leupeptin (100 ugs/ml) effectively blocked thrombin (0.2 u/ml) induced elevation of cytosolic calcium, but did not affect arachidonate induced elevation of platelet intracellular calcium levels. At a concentration of 100 ug/ml, Leupeptin effectively blocked thrombin (0.5u/ml) induced clot formation of platelet poor plasma, suggesting that it can exert its effect on thrombin by preventing fibrinogen degradation. Effective Ki for the competitive inhibition of thrombin induced hydrolysis of a chromogenic substrate, S2238, by Leupeptin was 2.4 uM. Leupeptin inhibition of platelet function was reversible by washing platelets free of the polypeptide. Results of our study demonstrate that Leupeptin inhibits thrombin induced platelet activation, probably by interfering with its proteolytic activity on the platelet surface membrane. However, inhibition of platelet surface membrane associated proteases did not prevent activation of platelets by other agonists. 相似文献
62.
检测198例各型乙肝患者血小板功能的五个项目:血小板总数、粘附试验、聚集试验、血块退缩、血小板第3因子有效性,发现各期乙肝患者血小板功能的异常有显著性差异(P<0.01).并提示乙肝患者除有血小板数量的改变外,还有质量的改变,因此,全面的血小板功能检测可作为估计乙肝患者肝损害程度的辅助指标. 相似文献
63.
R. B. Zotz G. Giers B. Maruhn-Debowski & R. E. Scharf 《British journal of haematology》1997,96(1):198-203
Genotyping of platelet alloantigens with the possibility of using any type of cellular material as a source of DNA has become a preferred procedure, particularly in thrombocytopenic patients when platelet counts are too low for phenotyping. Recently human platelet antigen 1 (HPA-1) has been identified as an inherited risk factor for coronary thrombosis. The different detection methods currently used have disadvantages for large-scale DNA diagnosis, including the need for electrophoresis (allele-specific restriction enzyme analysis, amplification with sequence-specific primers) or the potential risk of reduced specificity (allele-specific oligonucleotide hybridization). In this report we describe the adaptation of an automated oligonucleotide ligation assay to genotype HPA-1 in polymerase chain reaction (PCR)-amplified DNA samples. HPA-1a and HPA-1b phenotypes corresponded to the results of the different genotyping assays. The genotypes determined with the ELISA-based PCR-oligonucleotide ligation assay were in 100% concordance with the results obtained by conventional allele-specific restriction enzyme site analysis and PCR amplification with sequence-specific primers. The automated oligonucleotide ligation assay provides a rapid, reliable, nonisotopic method to genotype human platelet antigens that can rapidly be applied to large population screening. 相似文献
64.
J. P. De La Cruz S. Cámara M. A. Frutos F. Sánchez De La Cuesta 《European journal of clinical pharmacology》1992,43(3):307-309
Summary The antiproteinuric effect of the antiplatelet agent dipyridamole has been assessed after inhibiton of thromboxane B2 (TxB2) synthesis in 8 patients with confirmed membranous glomerulonephritis.
There were three study periods, each of 30 days, and 45 days apart, namely a washout period, treatment with dipyridamole 300
mg/d, and dipyridamole 225 mg/d plus aspirin 150 mg/d. On Days 1 and 30 of each study period serum and urine creatinine, 24-h
excretion of protein, creatinine clearance, platelet aggregometry on whole blood and serum TxB2 were measured.
Treatment with dipyridamole alone or with aspirin produced significant inhibition of platelet aggregation and a fall in 24-h
protein excretion; the latter amounted to 54% with dipyridamole alone and 56 % with dipyridamole plus aspirin (NS). Dipyridamole
plus aspirin caused an 82 % reduction in serum TxB2. 相似文献
65.
凝血酶(thromibin,Ⅱa)是一种生成于损伤处血管内皮细胞多功能蛋白酶,它是参与凝血过程各个环节反应中的关键酶。在发挥止血作用的同时,还可能诱导炎症、增生及修复等反应。最近发现的凝血酶受体(thrombin receptor,TR)分子可能为解释上述现象提供了一个理论框架。同时,TRN端被Ⅱa切下的41个氨基酸片段是否具有特殊功效,值得研究探讨。 相似文献
66.
F. Fabris I. Cordiano F. Salvan R. Ramon M. Valente G. Luzzatto A. Girolami 《European journal of haematology》1997,58(1):40-45
Abstract: We studied 47 subjects belonging to 13 unrelated families with a history of mild haemorrhagic diathesis and chronic thrombocytopenia. 36 patients presented some degree of thrombocytopenia: 7/36 (19%) had slight thrombocytopenia (100–150×109/L); 26/36 (72%) had mild thrombocytopenia (50–100×109/L) and 3/36 (8%) had severe thrombocytopenia (<50×109/L). No correlation was observed between platelet count and the degree of haemorrhagic diathesis, which was mild in the majority of patients. Transmission was autosomal dominant. Platelet anisocytosis, increased percentage of large platelets and absence of leukocyte inclusions were observed in 26/30 (87%) of the examined blood smears. The ultrastructural appearance of platelets was normal. Megakaryocytes appeared normal in number in 10/10 patients, but showed asynchronous nuclear-cytoplasm maturation and mainly nonlobulated nuclei. Platelet aggregation was studied in 26 patients and either increased or decreased curves were variably observed in response to different aggregating agents. Platelet-associated IgG (PAIgG) was increased in 18/31 (58%) patients, while serum autoantibodies against platelet glycoproteins Ib/IX or IIb/IIIa were demonstrable in only 1 case. An increased expression of platelet surface glycoproteins Ib and IIb/IIIa, as studied by murine monoclonal antibodies binding in 17 cases, was observed. Platelet survival performed by 111In-oxine-labelled autologous platelets was normal in the 3 studied patients. Congenital macrothrombocytopenia confirms to be a distinct clinical disorder for which the name of “chronic isolated hereditary macrothrombocytopenia” is proposed. 相似文献
67.
Blood platelets in severely injured burned patients 总被引:2,自引:0,他引:2
Yoshiaki Takashima 《Burns : journal of the International Society for Burn Injuries》1997,23(7-8):591-595
Unbelievable decrease of blood-platelet in the severely burned patients during the treatment of skingrafting caused two patients to unexpected death. From the records of changes of platelet number, a certain ‘platelet curve’ was made. By observing the curve, our treatments of skingrafting were carried out during the stable period and from then on we had no death cases. 相似文献
68.
69.
Comparison of the effect of intravenous ketoprofen, ketorolac and diclofenac on platelet function in volunteers 总被引:1,自引:0,他引:1
Background : Nonsteroidal anti–inflammatory drugs (NSAIDs) inhibit prostaglandin synthesis which may result in impaired platelet function. Because NSAIDs have different abilities to inhibit cyclo–oxygenases we compared the effect of intravenous ketoprofen, ketorolac and diclofenac on platelet function in volunteers. Methods : Ten healthy male volunteers were given ketoprofen 1.4 mg kg-1, ketorolac 0.4 mg kg-1 and diclofenac 1.1 mg kg-1 in saline i.v. on three different occasions, at more than one–week intervals, in a randomized double–blind crossover study. Platelet function was evaluated before (sample 0), 2 (sample 2) and 24 h (sample 3) after the beginning of the infusion. Results : Two of the volunteers had no secondary platelet aggregation in their aggregation curves before the experiment (sample 0, studied three times) and their results were excluded from the final analysis. Diclofenac inhibited adrenaline (0.9 μg–ml-1) induced platelet aggregation less (median maximal aggregation 22.5%) than ketoprofen (18.3%) and ketorolac (15.7%) (P<0.05) in sample 2. In the ketorolac group in sample 3 an impairment of adrenaline (0.9 ng ml-1) induced platelet aggregation was still seen (26.7%) (P<0.05) but not in the other groups. Diclofenac did not affect adenosine diphosphate (ADP) induced platelet aggregation. However, ketorolac caused an impairment in ADP (3 μM and 6 μM) induced platelet aggregation and ketoprofen in ADP (6 μM) induced platelet aggregation in sample 2. Bleeding time was prolonged (P<0.05) after ketoprofen and ketorolac (sample 2) but not after diclofenac. Platelet retention on glass beads was unaffected by the tested drugs. Conclusion : Ketoprofen, ketorolac and diclofenac caused a reversible platelet dysfunction. Diclofenac had the mildest effect, while platelet dysfunction was still seen 24 h after the beginning of ketorolac. 相似文献
70.
本文利用国产抗血小板膜糖蛋白单克隆抗体分别制备出抗人血小板膜糖蛋白(GPIb、GPⅡb及GPⅢa)的免疫金探针。以此探针检测了9例“刺参诱聚缺陷症”患者及2例血小板无力症患者血小板膜糖蛋白。结果表明“剌参诱聚缺陷症患者”其静息状态下血小板GPIb、GPⅡb正常,GPⅢa低于正常时照组(P<0.01)。经“剌参”刺激后,GPⅢa仍低于正常(P<O.01),而经ADP刺激后GPⅢa可恢复正常。血小板无力症患者其静息状态下GPIb正常,GPⅡb、GPⅢa、均低于正常(P<0.01)。经“刺参”、ADP刺激后GPⅢa、GPⅡb仍低于正常,(P<O.01)。 相似文献